Biomarkers for late-onset neonatal sepsis

The diagnosis of healthcare-associated infections is problematic because of the overlap between clinical signs associated with 'normal'physiological disturbances and those of bacteremia or fungemia. Earlier diagnosis of sepsis in critically ill infants would enable timely administration of antibiotics and discontinuation of treatment in infants with a low probability of sepsis.

A recent study by Ng et al. identified two novel biomarkers for late-onset neonatal sepsis: the des-arginine variant of serum amyloid A and apolipoprotein C-II.

These markers may be of value in the identification of neonates with bacteremia or fungemia.

Author: Richard PolinTara Randis
Credits/Source: Genome Medicine 2010, 2:58

Published on: 2010-09-06

Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.

Comments Page 0 of 0

There are currently 0 comments to display.

+ Add New Comment

Custom Search